2Dupin N, Diss T L, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma[J]. Blood, 2000, 95(4): 1406-1412.
3Mikala G, Xie J, Berencsi G, et al. Human herpesvirus 8 in hematologic diseases[J]. Pathol Oncol Res, 1999, 5(1): 73-79.
4Belec L, Mohamed A S, Authier F J, et al. Human herpesvirus 8 infection in patients with POEMS syndrome- associated multicentric Castleman's disease[J]. Blood, 1996, 93(11): 3643-3653.
5Du M Q, Diss T C, Liu H, et al. KSHV and EBV-associated germinotropic lymphoproliferative disorder[J]. Blood, 2002, 100(9):3415 -3418.
6Du M Q, Liu H, Diss T C, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders [J].Blood, 2001, 97(7): 2130-2136.
7Norihiro N, Mitsuko S, Yoshihito S, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy[J].Blood, 2000, 95(1):56-63.
8Frizzera G. Castleman's disease and related disorders[J]. Semin Diag Pathol, 1988,5:346-364.
9Corbellino M, Bestetti G, Scalamogna C, et al. Long-term remission of Kaposi sarcoma- associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy [J]. Blood,2001, 98(12): 3473-3478.
10Beck J T, Hsu S M, Wijdenes J, et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody[J]. N Engl J Med, 1994, 330: 602-608.
3Belgnaoui F, Raki S, Douira L, et al. Maladie de behcet tres thrombogene associee a une maladie de Castelman eta une amylose renale [ J ]. Ann Dermatol Venereol, 2006,133 (3) :278-280.
4Cervera Grau J M, Galiana Esquerdo G, Lorca Ferrandiz C, et al. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with muhicentric Castleman's disease induced with anti-CD20[J]. Clin Transl Oncol, 2006,8(7) : 540-541.
5Rosado R, Gallardo A, Mezquita S, et al. Enfermedad de Castleman unicentrica. Utilidad de la laparoscopia en su di- agnostico y tratamiento[J]. Cir Esp, 2006,80(3):181-182.
6Akahane D, Kimura Y, Sumi M, et al. Effectiveness of long term administration of humanized anti-interleukin-6 receptor antibody (tocilizumab) for muhicentric Castleman's disease with pulmonary involvement [ J ]. Rinsho Ketsueki, 2006,47 ($) :748-752.
7Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of inter-leukin-6 (IL-6/BSF-2) in Castleman disease [J]. Blood, 1989,74(5):1360-1367.
8Katsume A, Saito H, Yamada Y, et al. Anti-interleukin 6 (IL-6) receptor antibody suppresses Castlemang disease like symptoms emerged in IL-6 transgenic mice [ J ]. Cytokine, 2002,20(6) :304-311.
9Mark Bower. How I treat HIV-associated multicentric Castle- man disease [J]. Blood, 2010,116(22) :4415-4421.
10Lv J, Zhang H, Zhou F, et al. Antiglomerular basement membrane disease associated with Castleman disease [ J ]. Am J Med Sci, 2009,337(3) :206-209.
